Finepoint Capital LP - Q4 2022 holdings

$309 Thousand is the total value of Finepoint Capital LP's 44 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 68.0% .

 Value Shares↓ Weighting
TVTX SellTRAVERE THERAPEUTICS INC$21,583
-99.9%
1,026,300
-0.3%
6.98%
-16.3%
SellALGOMA STL GROUP INC$20,411
-99.9%
3,219,441
-13.4%
6.60%
-16.2%
FOLD SellAMICUS THERAPEUTICS INC$17,442
-99.9%
1,428,475
-15.4%
5.64%
-2.7%
CERE SellCEREVEL THERAPEUTICS HLDNG I$16,315
-99.9%
517,287
-3.7%
5.28%
+5.7%
ISEE SellIVERIC BIO INC$15,150
-99.9%
707,600
-28.4%
4.90%
-15.9%
SAGE SellSAGE THERAPEUTICS INC$14,561
-99.9%
381,765
-11.1%
4.71%
-14.8%
IOVA SellIOVANCE BIOTHERAPEUTICS INC$9,876
-99.9%
1,545,589
-2.6%
3.19%
-36.1%
SellDISH NETWORK CORPORATIONnote 12/1$9,645
-99.9%
15,000,000
-25.0%
3.12%
-28.3%
WPCAWS ExitWARBURG PINCUS CAPITAL CORP I-A*w exp 99/99/999$0-14,999
-100.0%
0.00%
TMACWS ExitMUSIC ACQUISITION CORP/THE*w exp 02/05/202$0-75,250
-100.0%
-0.00%
WPCBWS ExitWARBURG PINCUS CAPITAL CORP I-B*w exp 99/99/999$0-125,000
-100.0%
-0.00%
HAACW ExitHEALTH ASSURANCE ACQUISITION C*w exp 11/12/202$0-643,000
-100.0%
-0.01%
REVHW ExitREVOLUTION HEALTHCARE ACQUISIT*w exp 12/31/202$0-432,639
-100.0%
-0.01%
CRHCWS ExitCOHN ROBBINS HOLDINGS CORP*w exp 08/28/202$0-904,000
-100.0%
-0.01%
SPGSWS ExitSIMON PROPERTY GROUP ACQUISITION HOLDINGS INC*w exp 02/04/202$0-335,200
-100.0%
-0.01%
FVTWS ExitFORTRESS VALUE ACQUISITION COR*w exp 12/31/202$0-225,000
-100.0%
-0.01%
FCAXWS ExitFORTRESS CAPITAL ACQUISITION C*w exp 99/99/999$0-392,000
-100.0%
-0.01%
GTPAW ExitGORES TECHNOLOGY PARTNERS INC*w exp 03/16/202$0-201,000
-100.0%
-0.01%
FVIVWS ExitFORTRESS VALUE ACQUISITION COR*w exp 03/18/202$0-306,513
-100.0%
-0.02%
KAHCWS ExitKKR ACQUISITION HOLDINGS I CORP*w exp 99/99/999$0-588,547
-100.0%
-0.02%
GTPBW ExitGORES TECHNOLOGY PARTNERS II INC*w exp 03/16/202$0-450,691
-100.0%
-0.02%
ExitSTARRY GROUP HOLDINGS INC*w exp 99/99/999$0-669,000
-100.0%
-0.03%
ExitGLOBAL BUSINESS TRAVEL GROUP*w exp 99/99/9999$0-913,000
-100.0%
-0.47%
ARGX ExitARGENX SEsponsored adr$0-28,770
-100.0%
-3.34%
RCUS ExitARCUS BIOSCIENCES INC$0-646,586
-100.0%
-5.56%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
YPF SOCIEDAD ANONIMA17Q4 201832.7%
IRSA INVERSIONES Y REP S A15Q2 201810.1%
CHENIERE ENERGY INC14Q1 201829.9%
ALLY FINL INC13Q4 201742.0%
CRESUD S A C I F Y A13Q4 20174.0%
BRIDGETOWN HOLDINGS LTD9Q3 20230.2%
ARES ACQUISITION CORP9Q3 20230.2%
CHURCHILL CAPITAL CORP V9Q3 20230.2%
CHURCHILL CAPITAL CORP VII9Q3 20230.1%
CHURCHILL CAPITAL CORP VI9Q3 20230.1%

View Finepoint Capital LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11
13F-HR2021-11-12

View Finepoint Capital LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (309294.0 != 309293.0)

Export Finepoint Capital LP's holdings